BioNexus Gene Lab Corp. Files 8-K
Ticker: BGLC · Form: 8-K · Filed: Mar 7, 2025 · CIK: 1737523
| Field | Detail |
|---|---|
| Company | Bionexus Gene Lab CORP (BGLC) |
| Form Type | 8-K |
| Filed Date | Mar 7, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 8-k, disclosure
TL;DR
BioNexus Gene Lab Corp. filed an 8-K on March 7, 2025. Details to follow.
AI Summary
BioNexus Gene Lab Corp. filed an 8-K on March 7, 2025, reporting a Regulation FD Disclosure and Financial Statements and Exhibits. The filing details the company's principal executive offices located in Kuala Lumpur, Malaysia, and confirms its incorporation in Wyoming. No specific financial figures or material events were detailed in the provided excerpt.
Why It Matters
This filing indicates BioNexus Gene Lab Corp. is providing updates or disclosures to the SEC, which could contain material information for investors.
Risk Assessment
Risk Level: low — The provided excerpt is a standard SEC filing notification and does not contain specific financial or operational details that would indicate immediate risk.
Key Players & Entities
- BioNexus Gene Lab Corp. (company) — Filer
- March 7, 2025 (date) — Filing Date
- Wyoming (jurisdiction) — State of Incorporation
- Kuala Lumpur (location) — Principal Executive Offices
FAQ
What specific event triggered this 8-K filing?
The filing indicates a 'Regulation FD Disclosure' and 'Financial Statements and Exhibits' as the item information, but the specific event triggering the disclosure is not detailed in the provided excerpt.
Where are BioNexus Gene Lab Corp.'s principal executive offices located?
The principal executive offices are located at Unit A-28-7, Tower A, Menara UOA Bangsar, No.5 Jln Bangsar Utama 1, 59000 Kuala Lumpur.
In which U.S. state is BioNexus Gene Lab Corp. incorporated?
BioNexus Gene Lab Corp. is incorporated in Wyoming.
What is the company's SEC file number?
The SEC file number for BioNexus Gene Lab Corp. is 001-41750.
When was the company formerly known as BioNexus Gene Lab Coporation?
The company's name change date from BioNexus Gene Lab Coporation was April 13, 2018.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 7, 2025 regarding BioNexus Gene Lab Corp (BGLC).